FDA has free-speech, safety issues to weigh in review of ‘off-label’ drug marketing rules

This article is from the source 'washpo' and was first published or seen on July 10, 2014 00:00 (UTC). It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.washingtonpost.com/national/health-science/fda-has-free-speech-safety-issues-to-weigh-in-review-of-off-label-drug-marketing-rules/2014/07/09/3708dd6a-fbc4-11e3-8176-f2c941cf35f1_story.html?wprss=rss_homepage

The article has changed 1 times. There is an RSS feed of changes available.